Cargando…
Hyperammonemic Encephalopathy: valproic acid-induced adverse reaction
INTRODUCTION: Hyperammonemic encephalopathy is an unusual but fatal consequence of patients being treated with valproic acid (VPA). The most relevant clinical features in cases of valproic acid-induced hyperammonemia include confusion, lethargy, vomiting, and increased seizure frequency and may prog...
Autores principales: | Gómez, E., Gallardo, L., Fernández, R., Talaya, E., Al Chaal, L., Rybak, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479009/ http://dx.doi.org/10.1192/j.eurpsy.2023.2235 |
Ejemplares similares
-
Valproic acid-induced hyperammonemic encephalopathy: a clinical case
por: Felizardo, M., et al.
Publicado: (2022) -
Valproic acid-induced hyperammonemic encephalopathy – a potentially fatal adverse drug reaction
por: Sousa, Carla
Publicado: (2013) -
Valproic Acid-induced Hyperammonemic Encephalopathy Promoted by Levetiracetam
por: Roh, Sook Young, et al.
Publicado: (2014) -
A Case of Valproic-Acid Induced Hyperammonemic Encephalopathy
por: Iqbal, Kinza, et al.
Publicado: (2021) -
Hyperammonemic Encephalopathy due to Valproic Acid and Topiramate Interaction
por: Twilla, Jennifer D., et al.
Publicado: (2014)